These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 28376824)

  • 21. Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
    Tsui J; Vittinghoff E; Anastos K; Augenbraun M; Young M; Nowicki M; Cohen MH; Peters MG; Golub ET; Szczech L
    Am J Kidney Dis; 2009 Jul; 54(1):43-50. PubMed ID: 19394735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.
    Ganesan A; Krantz EM; Huppler Hullsiek K; Riddle MS; Weintrob AC; Lalani T; Okulicz JF; Landrum M; Agan B; Whitman TJ; Ross MJ; Crum-Cianflone NF;
    HIV Med; 2013 Feb; 14(2):65-76. PubMed ID: 22808988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.
    Morlat P; Vivot A; Vandenhende MA; Dauchy FA; Asselineau J; Déti E; Gerard Y; Lazaro E; Duffau P; Neau D; Bonnet F; Chêne G;
    PLoS One; 2013; 8(6):e66223. PubMed ID: 23776637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
    Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
    Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
    Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
    J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.
    Rossi C; Cox J; Cooper C; Martel-Laferrière V; Walmsley S; Gill J; Sapir-Pichhadze R; Moodie EE; Klein MB;
    AIDS; 2016 Jun; 30(9):1403-311. PubMed ID: 26859371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.
    Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
    Kidney Int; 2017 Sep; 92(3):703-709. PubMed ID: 28532708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV infection and the incidence of CKD.
    Butt AA; Wang X; Fried LF
    Am J Kidney Dis; 2011 Mar; 57(3):396-402. PubMed ID: 21185632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients.
    Maalouf NM; Zhang S; Drechsler H; Brown GR; Tebas P; Bedimo R
    J Bone Miner Res; 2013 Dec; 28(12):2577-83. PubMed ID: 23677838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial changes in renal indices in chronic HCV patients with and without HIV co-infection receiving sofosbuvir and tenofovir-based therapies.
    Abdel Alem S; El Garhy N; El Khateeb E; Khalil M; Cordie A; Elsharkawy A; Fouad R; Esmat G; Abdelbary MS
    Trans R Soc Trop Med Hyg; 2023 Apr; 117(4):285-296. PubMed ID: 36397681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
    Mocroft A; Kirk O; Reiss P; De Wit S; Sedlacek D; Beniowski M; Gatell J; Phillips AN; Ledergerber B; Lundgren JD;
    AIDS; 2010 Jul; 24(11):1667-78. PubMed ID: 20523203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.
    Lee JJ; Lin MY; Yang YH; Lu SN; Chen HC; Hwang SJ
    Am J Kidney Dis; 2010 Jul; 56(1):23-31. PubMed ID: 20400217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal outcomes after up to 8 years of tenofovir exposure in HIV-HBV-coinfected patients.
    Boyd A; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Plaisier E; Lacombe K
    Antivir Ther; 2017; 22(1):31-42. PubMed ID: 27553871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.
    Rossi C; Saeed S; Cox J; Vachon ML; Martel-Laferrière V; Walmsley SL; Cooper C; Gill MJ; Hull M; Moodie EEM; Klein MB;
    AIDS; 2018 Mar; 32(6):751-759. PubMed ID: 29369156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD.
    Zhang H; Xu H; Wu R; Yu G; Sun H; Lv J; Wang X; Chi X; Gao X; Kong F; Zhang M; Hang L; Jiang J; Pan Y; Niu J
    Sci Rep; 2019 Feb; 9(1):1910. PubMed ID: 30760762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease in patients infected with human immunodeficiency virus (HIV) in an urban cohort.
    Brito RM; Nguyen DT; Johnson JR; Lai EJ; Castro RE; Albert AM; Barnes AS; Graviss EA; Suki WN
    PLoS One; 2019; 14(4):e0215575. PubMed ID: 30995263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan.
    Chen YC; Chiou WY; Hung SK; Su YC; Hwang SJ
    BMC Nephrol; 2013 Sep; 14():187. PubMed ID: 24011024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
    Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
    Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.